| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Surgery | 515 / 597 | 13th | Q4 |
| Urology | 110 / 123 | 10th | Q4 |
| Radiology, Nuclear Medicine and Imaging | 324 / 361 | 10th | Q4 |
| Oncology | 388 / 428 | 9th | Q4 |
| Nephrology | 82 / 88 | 7th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Onkourologiya
Onkourologiya is Scopus-indexed (Q4, CiteScore 0.4), WoS ESCI. Published by ABV-press Publishing House.
Checked against the index lists dated .
ISSN 1726-9776Verify ISSN ↗1996-1812Verify ISSN ↗
Publisher: ABV-press Publishing House
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Onkourologiya indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2016–present (also 2005–2008), best quartile Q4, CiteScore 0.4.
What quartile is Onkourologiya in Scopus?
Onkourologiya is Q4 in Surgery (rank 515 of 597), Q4 in Urology (rank 110 of 123) and Q4 in Radiology, Nuclear Medicine and Imaging (rank 324 of 361), by CiteScore 2025. It is ranked in 5 subject areas in all.
What is the impact factor of Onkourologiya?
Onkourologiya is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.4, which places it in quartile Q4 at the 13th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.126, quartile Q4, with an H-index of 7.
Who publishes Onkourologiya and what is its ISSN?
Onkourologiya is published by ABV-press Publishing House. Its print ISSN is 1726-9776 and its online ISSN is 1996-1812.
Is Onkourologiya in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is Onkourologiya open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Onkourologiya? — open metrics via OpenAlex
Onkourologiya has an h-index of 10 and a 2-year mean of 0.29 citations per paper (OpenAlex). Its Scopus CiteScore is 0.4, quartile Q4. On 2-year citations it ranks #478 of 585 Scopus journals in Surgery.
Onkourologiya published 56 papers in 2025; its busiest recent year was 2021 with 86. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Onkourologiya? — latest 91 articles, 2025–2026
In its latest 91 research articles (2025–2026), authors are most often from Russia (90.7%), Indonesia (2.2%) and Poland (1.6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Onkourologiya? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration90.7% of recent authorship from Russia
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.